Argan Inc

AGX is entrenched in a Stage 4 decline with price below declining 9, 21, and 50 EMAs following a decisive support failure. Both the medium- and short-term biases are bearish, favoring immediate sell-side participation as price rebounds off the 200 DMA into sloping EMA resistance. Despite extreme oversold readings, no stable repair or mean-reversion base has formed, justifying a Sell Now posture.

• ↑Q1 2027 revenue $291M (+50% YoY) driven by power segment boom
• ↑Net income $46M ($3.24/share), gross margin rose to 21% from 19%
• ↓Shares trade at high valuation with low earnings yield and poor book-to-price